University procurement is notoriously slow. TTO directors know the friction. Engaging external consultants means navigating sole-source justifications, purchase order requirements, budget approval cycles, and vendor compliance questionnaires. By the time you've cleared procurement, six months have passed and the technology you wanted to assess has already moved forward (or stalled indefinitely).
This article is written directly to TTO directors. It addresses every objection you might face and provides the exact language, pricing, and process to integrate Vantage into your procurement system—without the typical bureaucratic delays.
The Core Problem: You Know the Value, Procurement Doesn't
You understand that a quantified, independent assessment of commercial viability could transform how you prioritize technologies and present investment decisions to university leadership. But procurement doesn't care. From their perspective, Vantage is "just another consultant" and they'll ask: Why not use internal staff? Why not use a cheaper consulting firm? Why Vantage specifically?
The answer lies in the unique combination of clinical-technical expertise and validated scoring methodology. But you need to articulate that in procurement language.
Procurement Option 1: Standard Purchase Order (Net-30 Terms)
This is the simplest path. Vantage accepts standard university purchase orders with no complex master service agreements. Here's what you need:
- PO Amount: $4,500 for single technology assessment or $30,000 for cohort assessment of 8-12 technologies
- Payment Terms: Net-30 (invoice issued upon delivery of assessment)
- Vendor Setup: Minimal vendor questionnaire; SOC 2 compliance documentation available upon request
- Timeline: 2-3 weeks from PO to deliverable
That's it. No complex vendor relationship, no multi-year contract, no legal review required for standard professional services.
Procurement Option 2: Sole-Source Justification
If procurement requires a sole-source justification (which many universities do for contracts above a certain threshold), here's the exact language you can use:
Sole-Source Justification Language (Copy This)
"Vantage Biomedical Partners is selected on a sole-source basis due to their unique combination of clinical expertise (MD/DO credentials with regulatory pathway knowledge) and quantified proprietary assessment methodology that has been validated against documented medical device commercializations. No other consulting firm combines equivalent depth in clinical evaluation, biomedical engineering assessment, and regulatory/reimbursement analysis within a single scoring framework. The Vantage methodology is proprietary and differentiated from generic technology assessment consulting firms that lack medical device commercialization expertise. This assessment is a one-time engagement for technology evaluation and does not establish ongoing relationship requiring competitive bidding for future engagements."
That language is genuine and defensible. It's not just marketing—it reflects a real differentiation. Procurement will accept it because it's specific, factual, and demonstrates that you've conducted due diligence.
Procurement Option 3: Budget-Friendly Pricing for Discretionary Spend
Most TTOs have some discretionary budget that doesn't require VP-level approval. At $4,500 per assessment, Vantage often fits within that discretionary spend threshold. Check with your finance office, but many universities allow individual departments $5K-$10K in discretionary consulting spend without additional approval cycles.
If you're assessing 8-12 technologies in a cohort, the cost is $30K, which is comparable to what you're already spending on patent prosecution costs per technology. Frame it that way to your finance office: "We spend $20-30K per patent filing in prosecution costs. A single $30K cohort assessment of 8 technologies tells us which ones are worth pursuing from a commercial viability perspective, improving ROI on our patent portfolio."
Procurement Option 4: Grant Compatibility (The Hidden Budget)
Many TTOs have access to funding sources that allow external consultant costs. These include:
- NIH SBIR/STTR Grants: Vantage assessments can be included in SBIR/STTR budgets as "consultant" line items. Cost is readily justifiable as an evaluation service supporting commercialization strategy.
- NSF I-Corps Supplemental Funding: I-Corps programs often have budget for external evaluations to validate commercialization hypotheses. Vantage fits perfectly.
- State Innovation Grants: Many states (California, Massachusetts, New York, Texas, etc.) offer technology transfer grants that explicitly allow external expert evaluations. Check your state's innovation office.
- University Incubator Funds: If your TTO manages an incubator or has access to innovation funding, those budgets typically have consultant line items.
This is a game-changer for cash-constrained TTOs. The assessment cost may already be covered by existing grants. Check your grant budgets before assuming you need to fund Vantage from your TTO discretionary budget.
Procurement Option 5: Multi-Year Service Contract
If you're confident about ongoing assessment needs, Vantage can establish a standing service contract. Example structure:
- Year 1: $30,000 for cohort assessment of 8-12 technologies
- Year 2: $30,000 for next cohort assessment
- Year 3: $30,000 for refresh assessment
This locks in pricing, simplifies procurement (single contract covers multiple years), and gives you predictable budget allocation. Most universities prefer multi-year contracts because they reduce administrative overhead.
Data Security: Addressing the University's Risk Concerns
Many universities will ask about data security. Here's what you should know:
- No Data Retention: Vantage does not retain client data post-engagement. Assessment data is deleted upon contract completion.
- Air-Gapped Option: For universities with proprietary research concerns, Vantage can conduct assessments in a restricted environment with limited data transfer.
- SOC 2 Type II Compliance: Vantage follows SOC 2 Type II security standards. Compliance documentation is available for university information security review.
- FERPA/HIPAA Compliance: Vantage protocols ensure no personally identifiable information is collected or retained.
These are standard data security commitments. Your university's IT office will be satisfied with SOC 2 compliance documentation.
Timeline from PO to Deliverable
Typical Procurement Timeline
- Day 1: TTO director initiates procurement request
- Days 1-5: Procurement processes PO (depends on complexity; can be expedited)
- Day 5: PO issued to Vantage
- Days 5-10: Initial technology intake meeting and data gathering
- Days 10-15: Assessment execution
- Days 15-21: Report generation and quality review
- Day 21: Deliverable issued to TTO director
- Day 30: Invoice payment (Net-30 terms)
From procurement initiation to assessment deliverable typically takes 3-4 weeks. If your university has expedited procurement processes, it can be faster. This is faster than waiting for external consultant RFPs (which typically take 6-8 weeks).
The Exact Steps You Take Tomorrow
Here's what a TTO director should do to move forward:
- Contact Vantage at contact@vantagebiomedical.com with: (a) your technology portfolio size, (b) how many technologies you want to assess in first cohort, (c) your university's vendor questionnaire template (if required).
- Prepare your sole-source justification using the language provided above. Send to your procurement office along with Vantage's company information and service description.
- Work with procurement to issue a standard PO for either a single assessment ($4,500) or cohort assessment ($30,000).
- Once PO is issued, coordinate with Vantage on technology intake (typically 2-3 technologies to start).
- Schedule a 30-minute kickoff call with Vantage to define assessment scope and timeline.
- Receive final assessment report 2-3 weeks later.
Removing the Final Objection: "Why Not Use Internal Staff?"
Your CFO or VP might ask: "Why hire external consultants when our internal staff can evaluate technologies?" Here's the response:
Your internal TTO staff excels at patent law, licensing, and relationship management. They don't have clinical expertise or regulatory pathway knowledge. Asking a patent attorney to assess FDA regulatory risk is like asking an engineer to assess clinical outcomes—they can learn, but they're outside their domain of expertise.
An independent clinical-technical assessment brings two things internal staff can't: (1) clinical credibility (MD/DO evaluation of the science), and (2) third-party validation that internal evaluations lack. When you present a Vantage Score to university leadership or licensing partners, you're presenting an independent assessment, not internal spin.
The Bottom Line
University procurement doesn't have to be a barrier. Vantage is designed to work within academic procurement constraints: standard POs, Net-30 terms, no complex MSAs, clear sole-source justification, and often grant-compatible cost structure.
The friction you expect—6 months of paperwork, multiple approval cycles, vendor compliance questionnaires—doesn't apply here. From procurement initiation to deliverable, expect 3-4 weeks. That's actually faster than most university vendor relationships.
"The best time to assess commercial viability is before you invest resources in patent prosecution and commercialization. University procurement shouldn't be the blocker."
References
- AUTM. "Technology Transfer Best Practices Guide." autm.org
- NIH. "SBIR/STTR Budget and Proposal Guide." sbir.gov
- NSF. "I-Corps Program Guidelines." nsf.gov
- NACUBO. "University Procurement Guidelines and Best Practices." nacubo.org
- National Institutes of Health. "Consultant Cost Guidance for Federal Grants." nih.gov
Need a Custom Analysis?
Our proprietary risk framework has been validated against documented medical device companies. Get a complimentary regulatory readiness assessment for your submission strategy.